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Abstract
Purpose The reasons for the comorbidity between depressed mood and poor sleep are not well understood.
Method Participants were 5172 adults aged 50 years and older from the English Longitudinal Study of Ageing. Sleep was
measured via self-report and depressive symptoms using the Centre for Epidemiological Studies Depression scale.
Results Greater depressive symptoms and sleep complaints were associated with female sex, non-cohabitation, relative
poverty, smoking, infrequent physical activity, infrequent alcohol consumption, higher body mass index (BMI), diagnosis
of hypertension, coronary heart disease, diabetes/high blood glucose, pulmonary disease, arthritis, and higher levels of
fibrinogen and C-reactive protein (all p < 0.05). At a 4-year follow-up, depressive symptoms and sleep complaints were
both predicted by baseline depressive symptoms and sleep complaints, relative poverty, smoking, physical inactivity, BMI,
and arthritis (all p < 0.05).
Conclusion Depressive symptoms and sleep complaints share a range of correlates cross-sectionally and prospectively.
These findings highlight the common comorbidity between depressive symptoms and sleep complaints underscoring the
need for further research to understand their combined detrimental effect on long-term health and wellbeing.
Keywords Depressive symptoms . Sleep complaints . Health behaviour . Physical illness . C-reactive protein . Fibrinogen
Introduction
Depression is now one of the leading causes of global disease
burden [1] and subclinical levels of depression in community-
dwelling adults are known to be highly prevalent in England [2].
Elevated depressive symptoms have been associated with an
array of poor physical health outcomes, including increased risk
of diabetes [3] and coronary heart disease [4]. Late-life depres-
sion has been associated with dementia [5] and there is some
evidence for an association with cancer [6], though this literature
is mixed [7]. Understanding why depressive symptoms are ad-
versely related to health is therefore of great importance.
The high level of symptom overlap between depression
and physical illness has been proposed as a potential reason
for the apparent association. Such hypotheses imply residual
confounding may exist, though this explanation overlooks the
potential role of somatic correlates of depression. One such
example is poor sleep [8–10].
The co-occurrence of depression and sleep symptoms has
long been recognised [11] though the temporal sequence has
been difficult to establish. Depression is frequently accompa-
nied by adverse changes to sleep, such as problems with sleep
onset, sleep maintenance, and early morning awakenings [10];
these self-reported findings have also been confirmed using
objective readings of sleep collected via actigraphy and
polysomnography [9]. However, despite sleep disturbance be-
ing a diagnostic characteristic of major depression, we also
know that depression is highly prevalent in those with insom-
nia [12] and that insomnia sufferers are at increased risk of
developing a new-onset depressive episode compared to those
without sleep problems [13] and such results have been sup-
ported using meta-analysis [14, 15]. Adults sleeping short
sleep hours, typically 5 h or less per night, are also at an
increased risk of depression [16]. Abnormal sleep in turn is
associated with poor health outcomes and an array of physical
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illnesses [17, 18]. Some authors have urged caution in
interpreting the longitudinal associations suggesting instead
that sleep disturbance is a prodromal symptom of depression
[19], highlighting the need for further understanding of this
issue.
The reason why depression and sleep symptoms co-occur
is not well understood. We attempted to address this question
by examining the participant profiles of adults taking part in
the English Longitudinal Study of Ageing (ELSA). These
were exploratory analyses which aimed to shed light on the
sociodemographic, behavioural, clinical, and biological corre-
lates of depressive symptoms and poor sleep. We also aimed
to elucidate if depressive symptoms and poor sleep complaints
measured at a 4-year follow-up would be predicted by similar
factors. Finally, we aimed to assess the interaction between
depressive symptoms and sleep complaints for predicting
these same symptoms over time.
Methods
Sample and Study Design
Data were taken from ELSA, a nationally representative gen-
eral population study of adults aged 50 years and older living
in England. Further details can be found elsewhere [20]. The
sample is followed up every 2 years from 2002 onwards, with
refresher samples being added at waves 3, 4, and 6. At every
wave, participants complete a computer-assisted personal in-
terview plus a self-completion questionnaire. On alternate
waves, a nurse visit is conducted to allow for the collection
of blood samples and objective assessments of physical func-
tion, such as body mass index (BMI).
This current paper reports data spanning 4 years, from
wave 4 (2008/9) through to wave 6 (2012/2013), of core
members. Wave 4 and wave 6 were selected since these are
the only points at which sleep data were collected. Analysis
was performed on a sample of 5172 participants (65.71 ±
8.76 years; 54.6% female) who provided data on all variables,
out of a total available sample of 7744 core members. Missing
data on hs-CRP (n = 1346), fibrinogen (n = 1428), and BMI
(n = 324) means analyses using these variables were per-
formed on a reduced sample size, as indicated in Tables 1, 2,
and 3.
Measures
Depressive Symptoms and Sleep Symptoms
Depressive symptoms were measured at wave 4 and wave 6
using the 8-item Centre for Epidemiological Studies
Depression scale (CES-D). The CES-D measures symptoms
that can be used to identify people at risk of depression, rather
than clinical depression per se [21]. The psychometric prop-
erties of the 8-item version have been shown to be comparable
to the original 20-item version [22]. For the purpose of anal-
yses described here, the sleep item was removed from the
CES-D so as to avoid the issue of shared variance with the
sleep problems measure. We computed a summary score by
adding responses to all seven dichotomous questions (possible
range 0–7). Analyses were performed using this summary
score, though for descriptive purposes and post hoc tests, we
also implemented the validated cut-off of 4 [19] to capture
low/high depressive symptoms. The Cronbach’s alphas for
the CES-D in this study were 0.796 and 0.744 (wave 4 and
6, respectively).
Sleep problems were measured with three questions refer-
ring to the most frequent insomnia symptoms, including dif-
ficulties falling asleep, waking up several times a night and
waking up in the morning feeling tired. These sleep items
were derived from the Jenkins Sleep Problems Scale [23].
Participants answered these questions with regard to the past
month. Items were rated on a 4-point Likert scale ranging
from Bnot during the past month^ to Bthree or more times a
week^. Scores were summed with higher scores indicating
more sleep problems. The Cronbach’s alphas in this study
were 0.603 and 0.585 (wave 4 and 6, respectively). Sleep
duration was measured with an open-ended question asking
participants about their sleep duration on an average week
night. A binary variable was created using the 75th percentile
on the Jenkins measure (equivalent to a score of 9/12 in our
sample) and a cut-off of 5 h per night to indicate those with
low/high sleep complaints. Our definition of short sleep dura-
tion as < 5 was chosen for its clinical relevance [24, 25].
Correlates
Correlates were all measured at baseline and were select-
ed since they have been found to be related to both de-
pressive symptoms [26–29] and sleep measures [18,
30–32]. Sociodemographic variables include age, sex,
and whether participants were married or cohabiting with
a partner. Socioeconomic status was defined as quintiles
of net financial wealth, which refers to participants’ gross
financial wealth with financial debt subtracted, with 1
representing the lowest wealth and 5 the highest. Height
and weight were collected during the wave 4 nurse visit
and BMI was derived using the standard formula (kg/m2).
Whether or not participants reported being a current
smoker (yes/no) and frequency of alcohol consumption
(<twice a year/never (rarely), 1–2 times a month/every
2 months (occasionally), 1–4 times per week, >5 times
per week) were also considered. Participants reported the
frequency in which they engaged in vigorous, moderate,
and mild physical activity and we used these data to de-
rive two possible categories reflecting regularity of
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physical activity: moderate/vigorous activity once a week
or less, moderate/vigorous activity more than once a
week. Doctor diagnosis of hypertension was self-
reported (yes/no) and these responses were combined with
objective assessments taken at the nurse visit (hyperten-
sion defined as systolic blood pressure > 140 and diastolic
blood pressure > 90) to generate a binary variable (yes/
no). Doctor diagnosed physical illnesses were self-
reported and included coronary heart disease (defined as
angina and/or myocardial infarction), arthritis (defined as
including both rheumatoid and osteoarthritis), pulmonary
disease, cancer, and diabetes/high blood glucose.
Biomarkers were assessed from blood drawn from par-
ticipants’ forearm during the nurse visit and included high
sensitivity C-reactive protein (hs-CRP) and fibrinogen.
Participants who had a clotting or bleeding disorder and
those on anti-coagulant medication did not provide blood
samples. Fasting samples, defined as not eating or drink-
ing for 5 h prior to blood draw, were collected where
possible and when not otherwise contraindicated (e.g. >
80 years, diabetic, frail or unwell, ever had a seizure). Hs-
CRP was measured using the N Latex CRP mono immu-
noassay on the Behring Nephelometer II analyser.
Fibrinogen was analysed using a modification of the
Clauss thrombin clotting method on the Organon
Teknika MDA 180 analyser. All blood samples were
analysed at the Royal Victoria Infirmary laboratory in
Newcastle upon Tyne, UK (for a detailed description of
blood analyses see [33]).
Statistical Analysis
Data were assessed for assumptions of parametric data
prior to analysis. Extreme outliers greater than 3 standard
deviations from the mean were removed from the fibrin-
ogen and hs-CRP data and since the hs-CRP data were
positively skewed, logarithmic transformation was per-
formed to normalise the distribution. Associations be-
tween depressive symptoms and sleep complaints and
the potential correlates were tested using Pearson’s corre-
lations, t tests, ANOVAs, and chi-square tests, as appro-
priate. Linear regression and logistic regression analyses
were performed to assess the prospective association be-
tween the sociodemographic, behavioural, and clinical
variables measured at wave 4 and both depressive symp-
toms and sleep complaints measured at wave 6 as appro-
priate. Predictor variables were entered into models simul-
taneously. These analyses also controlled for baseline de-
pressive symptoms and sleep complaints to explore the
direction of the association between depression and poor
sleep. Importantly, we included a mean-centred interac-
tion term in these models for baseline depressive symp-
toms × baseline sleep complaints. Separate analyses were
performed for depressive symptoms and sleep complaints.
Results are presented as standardised coefficients (Beta)
for linear regression and odds ratios for logistic regression
with 95% confidence intervals (CI). We have presented
the models excluding fibrinogen and hs-CRP to maximise
the sample size, though analyses including biomarkers are
reported in the text. Finally, post hoc tests were performed
to examine the significant interaction results in greater
detail using fully adjusted linear and logistic regression
models as appropriate. Specifically, we split the dataset
by low/high depressive symptoms (CES-D ≥ 4) to test
the effect of baseline sleep complaints on follow-up de-
pressive symptoms at wave 6, and for models using base-
line depressive symptoms to predict wave 6 sleep com-
plaints we split the file by wave 4 low/high sleep com-
plaints. Data were analysed using SPSS version 21. Exact
p values are reported throughout.
Results
The characteristics of the sample are displayed in Table 1.
The mean age of the sample was 65.71 years (±
8.76 years) and the majority were of White ethnic origin
and married or cohabiting with a partner. Most partici-
pants did not smoke, but only a third engaged in moderate
or vigorous activity at least once a week. The mean BMI
of 28.35 kg/m2 (± 5.20 kg/m2) is reflective of the high
levels of obesity in the sample; 30.2% of participants
had a BMI ≥ 30. Physical illness was prevalent in the
sample, with almost half of participants reporting hyper-
tension and over a third reporting arthritis. Mean depres-
sive symptom scores at baseline (0.90 ± 1.56) were overall
low; however, 9% of participants scored above the thresh-
old of 4 for the CES-D indicating possible depression.
Interestingly, of those with high levels of depressive
symptoms (CES-D ≥ 4), very few reported low sleep com-
plaints (131/460, 3.7%). This reflects the high comorbid-
ity between depressive symptoms and poor sleep using
our cut-offs in our sample (χ2 = 397.44, p < 0.001).
Associations Between Depressive Symptoms
and Sleep Complaints and Demographic, Behavioural
and Biological Correlates at Wave 4
Table 2 shows the results from the univariate analyses com-
paring depressive symptom scores on the CES-D and those
with and without high sleep complaints across a wide range of
potential correlates at wave 4. The results show that apart from
age, ethnicity, stroke, and cancer, higher depressive symptoms
and high sleep complaints were similarly associated to
sociodemographic, behavioural, clinical, and biological vari-
ables, compared to those lower in these respective symptoms.
Int.J. Behav. Med.
Specifically, greater depressive symptoms and high sleep
complaints were both associated with female sex, non-cohab-
itation, having lower wealth, smoking, engaging in less phys-
ical activity, consuming alcohol less frequently, having a
higher BMI, reporting a diagnosis of hypertension, CHD,
diabetes/high blood glucose, pulmonary disease, or arthritis
and having higher circulating levels of fibrinogen and hs-
CRP (all p < 0.05). Older age (r = 0.048, p = 0.001) and non-
White ethnicity (t = − 2.335, p = 0.020) were associated with
higher depressive symptoms, as were reporting a positive di-
agnosis of stroke (t = − 2.016, p = 0.044) and cancer (t = −
4.022, p < 0.001); however, congruent associations were not
observed for low/high sleep complaints.
Predicting Depressive Symptoms and Sleep
Complaints at Wave 6
Regression analyses were performed to assess the prospective
association between the sociodemographic, behavioural, and
clinical variables measured at wave 4 and both depressive
symptoms (linear regression) and sleep complaints (logistic
regression) measured at wave 6. Results for these analyses
are displayed in Table 3. Fibrinogen and hs-CRP were both
non-significant predictors and were thus removed from the
models to maximise the sample size (N = 4848). Specifically,
when the biomarkers were included in the model (N = 3579),
both fibrinogen and hs-CRP were non-significant predictors
of depressive symptoms (fibrinogen: β = − 0.022, 95% CI
0.164–0.035, p = 0.207; hs-CRP: β = 0.015, 95% CI −
0.030–0.073, p = 0.406) and sleep complaints (fibrinogen:
OR 0.983, 95% CI 0.812–1.190, p = 0.860; hs-CRP: OR
1.045, 95% CI 0.946–1.154, p = 0.391) at follow-up.
Analyses predicting wave 6 depressive symptoms showed
significant predictors to include greater baseline depressive
symptoms (β = 0.397, 95% CI 0.365–0.422), high baseline
sleep complaints (β = 0.067, 95% CI 0.135–0.311), older
age (β = 0.044, 95% CI 0.003–0.013), higher BMI (β =
0.053, 95% CI 0.008–0.023), pulmonary disease (β = 0.032,
95%CI 0.054–0.440), and arthritis (β = 0.050, 95%CI 0.076–
0.240). Negative associations were also found, with lower
wealth (β = − 0.028, 95% CI − 0.062–0.000), being a non-
smoker (β = − 0.044, 95% CI − 0.326 −0.084) and not engag-
ing in regular moderate/vigorous physical activity (β = −
0.039, 95% CI 0.212 −0.044) being associated with a greater
depressive symptoms 4 years later. Interestingly, we also
found a significant depressive symptoms × sleep complaints
interaction (β = 0.030, 95% CI 0.012–0.170). We performed a
post hoc fully adjusted linear regressionmodel to examine this
interaction further. Results showed that baseline sleep com-
plaints were a significant predictor of greater depressive
symptoms at wave 6 follow-up only among those participants
with low (i.e. CES-D < 4) baseline depressive symptoms (β =
0.128, 95% CI 0.290–0.462, p < 0.001) and not high (i.e.
CES-D ≥ 4) (β = 0.063, 95% CI − 0.188–0.829, p = 0.217).
Analyses predicting the increased odds of sleep complaints
at wave 6 showed baseline depressive symptoms (OR 6.795,
95% CI 5.860–7.879) and sleep complaints (OR 1.138, 95%
CI 1.083–1.195) to be significant predictors. Female sex (OR
1.380, 95% CI 1.186–1.605), higher BMI (OR 1.016, 95% CI
1.002–1.031), and having arthritis (OR 1.363, 95% CI 1.174–
Table 1 Demographic, clinical and biological characteristics of the
sample (N = 5172)
Characteristic Mean ± SD orN (%)
Baseline sociodemographics
Age (years) 65.71 ± 8.76
Female 2824 (54.6)
Ethnicity—White 5088 (98.4)
Married/cohabiting 3740 (72.3)
Net financial wealth—quintiles
1 718 (13.9)
2 975 (18.9)
3 1060 (20.5)
4 1161 (22.4)
5 1258 (24.3)
Baseline health behaviours
Current smoker 630 (12.2)
Moderate/vigorous physical activity ≥ 1 a week 1608 (31.1)
Alcohol consumption
> 5 times per week 1205 (23.3)
1–4 times per week 2073 (40.1)
1–2 times a month/every 2 months (occasional-
ly)
944 (18.3)
Twice a year/never (rarely/never) 950 (18.4)
Body mass index (kg/m2)* 28.35 ± 5.20
Baseline clinical factors
Hypertension 2820 (45.5)
CHD 477 (9.2)
Stroke 178 (3.4)
Diabetes/high blood glucose 486 (9.4)
Cancer 238 (4.6)
Pulmonary disease 208 (4.0)
Arthritis 1922 (37.2)
Baseline biomarkers
Fibrinogen (g/l)** 3.33 ± 0.52
hs-CRP (mg/l)*** 3.02 ± 3.53
Baseline and follow-up mood and sleep problems
Wave 4 CES-D 0.90 ± 1.56
Wave 6 CES-D 0.90 ± 1.55
Wave 4 sleep complaints 1584 (30.6)
Wave 6 sleep complaints 1626 (31.4)
*N = 4848
**N = 3744
***N = 3826
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Table 2 Baseline associations between depressive symptoms and sleep complaints and sociodemographic, behavioural and clinical variables (N =
5172)
Depressive symptoms Sleep complaints
Mean (SD) Test statistic p Mean ± SD or N (%) Test statistic p
Low (n = 3588) High (n = 1584)
Sociodemographics
Age – r = 0.048 0.001 65.72 ± 8.69 65.68 ± 8.93 t = 0.165 0.869
Sex
Male 0.67 ± 1.35 t = − 9.869 < 0.001 1797 (50.1) 551 (34.8) χ2 = 103.750 < 0.001
Female 1.10 ± 1.69 1791 (49.9) 1033 (65.2)
Ethnicity
White 0.90 ± 1.56 t = − 2.335 0.020 3534 (98.5) 1554 (98.1) χ2 = 1.040 0.340
Non-White 1.30 ± 1.83 54 (1.5) 30 (1.9)
Cohabiting
No 1.47 ± 1.90 t = − 16.570 < 0.001 916 (25.5) 516 (32.6) χ2 = 27.250 < 0.001
Yes 0.69 ± 1.35 2672 (74.5) 1068 (67.4)
Wealth
1 (lowest) 1.64 ± 2.03 F = 70.128 < 0.001 386 (10.8) 332 (21.0) χ2 = 167.084 < 0.001
2 1.10 ± 1.70 618 (17.2) 357 (22.5)
3 0.87 ± 1.48 728 (20.3) 332 (21.0)
4 0.70 ± 1.38 862 (24.0) 299 (18.9)
5 (highest) 0.54 ± 1.15 994 (27.7) 264 (16.7)
Health behaviours
Smoker
No 0.82 ± 1.47 t = 10.142 < 0.001 3195 (89.0) 1347 (85.0) χ2 = 16.510 < 0.001
Yes 1.49 ± 2.03 393 (11.0) 237 (15.0)
Physical activity
< 1 session/week 1.04 ± 1.66 t = 9.757 < 0.001 2325 (64.8) 1239 (78.2) χ2 = 92.379 < 0.001
≥ 1 session/week 0.59 ± 1.27 1263 (35.2) 345 (21.8)
Alcohol
> 5 times/week 0.66 ± 1.35 F = 61.563 < 0.001 897 (25.0) 308 (19.4) χ2 = 90.567 < 0.001
1–4 times/week 0.75 ± 1.41 1506 (42.0) 567 (35.8)
Occasionally 0.96 ± 1.60 640 (17.8) 304 (19.2)
Rarely/never 1.48 ± 1.92 545 (15.2) 405 (25.6)
BMI* – r = 0.068 < 0.001 28.04 ± 4.92 29.07 ± 5.72 t = − 6.413 < 0.001
Clinical factors
Hypertension
No 0.81 ± 1.48 t = −4.022 < 0.001 1668 (46.5) 684 (43.2) χ2 = 4.845 0.029
Yes 0.98 ± 1.62 1920 (53.5) 900 (56.8)
CHD
No 0.85 ± 1.52 t = − 7.335 < 0.001 3309 (92.2) 1386 (87.5) χ2 = 29.292 < 0.001
Yes 1.40 ± 1.87 279 (7.8) 198 (12.5)
Stroke
No 0.89 ± 1.56 t = − 2.016 0.044 3476 (96.9) 1518 (95.8) χ2 = 3.612 0.068
Yes 1.13 ± 1.55 112 (3.1) 66 (4.2)
Diabetes/high blood glucose
No 0.87 ± 1.53 t = − 4.957 < 0.001 3287 (91.6) 1399 (88.3) χ2 = 13.973 < 0.001
Yes 1.24 ± 1.78 301 (8.4) 185 (11.7)
Cancer
No 0.89 ± 1.55 t = − 4.022 < 0.001 3425 (95.5) 1509 (95.3) χ2 = 0.092 0.744
Yes 1.14 ± 1.76 163 (4.5) 75 (4.7)
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1.583) were also associated with increased odds of elevated
sleep complaints 4 years later. Relative wealth (e.g. the highest
wealth quintile (5) compared to the lowest [1] OR 0.761, 95%
CI 0.609–0.950), cohabitation (OR 0.740, 95% CI 0.621–
0.883), and regular physical activity (OR 0.830, 95% CI
0.750–0.978) were associated with a reduction in the odds of
sleep complaints at wave 6. We also found a significant de-
pressive symptoms × sleep complaints interaction (OR 0.836,
95% CI 0.724–0.965). We performed a post hoc fully adjusted
logistic regression model to examine this interaction further.
Results showed that baseline depressive symptoms were a
significant predictor of high sleep complaints at wave 6
follow-up only among those participants with low baseline
sleep complaints (OR 1.263, 95% CI 1.176–1.356,
p < 0.001) and not high (OR 1.034, 95% CI 0.975–1.096,
p = 0.268).
Discussion
This study aimed to characterise the similarities and differ-
ences in adults with depressive symptoms and sleep com-
plaints in order to better understand the common comorbidity
between the two. We investigated the sociodemographic, be-
havioural, clinical and biological correlates of depressive
symptoms and sleep complaints using data from ELSA, a
nationally representative cohort of adults aged 50 years and
older living in England. Our findings showed that older men
and women reporting elevated depressive symptoms and/or
sleep complaints shared a range of sociodemographic, behav-
ioural and clinical correlates that included female sex, non-
cohabitation, lower wealth, smoking, exercising less than
once a week, drinking alcohol infrequently, higher BMI, hav-
ing hypertension, CHD, diabetes/high blood glucose,
pulmonary disease, and arthritis, as well as higher levels of
hs-CRP and fibrinogen. When explored prospectively, elevat-
ed levels of depressive symptoms and sleep complaints also
shared common risk factors, namely, baseline depressive
symptoms, sleep complaints, relative poverty, smoking, phys-
ical inactivity, higher BMI, and arthritis. Interestingly, an in-
teraction effect was shown between baseline depressive symp-
toms and sleep complaints such that high sleep complaints at
wave 4 predicted greater depressive symptoms at wave 6 only
among those with low depressive symptoms at baseline, and
greater depressive symptoms at wave 4 predicted high sleep
complaints at wave 6 only in those with low sleep complaints
at baseline.
We found a high comorbidity between depressive
symptoms and poor sleep using the cut-offs employed in
our study since the vast majority (96.7%) of those
reporting elevated depressive symptoms also suffered
from disturbed and/or short sleep. While previous studies
have reported that approximately 50–60% of depressed
patients have clinically defined insomnia; in epidemiolog-
ical studies, results are consistent with our findings, with
reports that 83% of depressed individuals have at least
one insomnia symptom, with this figure rising to 90%
among depressed 55–64 year olds [34].
Our cross-sectional findings at baseline identified that
older adults with elevated depressive symptoms and sleep
complaints had similar sociodemographic, economic, behav-
ioural, and clinical correlates. Our study is the first, to the
best of our knowledge, to draw a parallel between these two
separate literatures. The evidence for the detrimental effect
of unhealthy lifestyles and negative health behaviours on
sleep and depression is well established [35–37].
Socioeconomic status was also identified in our analyses as
an important correlate of depressive symptoms and sleep
Table 2 (continued)
Depressive symptoms Sleep complaints
Mean (SD) Test statistic p Mean ± SD or N (%) Test statistic p
Low (n = 3588) High (n = 1584)
Pulmonary disease
No 0.87 ± 1.52 t = − 7.937 < 0.001 3472 (96.8) 1492 (94.2) χ2 = 18.878 < 0.001
Yes 1.74 ± 2.13 116 (3.2) 92 (5.8)
Arthritis
No 0.69 ± 1.36 t = − 13.112 < 0.001 2477 (69.0) 773 (48.8) χ2 = 192.683 < 0.001
Yes 1.27 ± 1.79 1111 (31.0) 811 (51.2)
Fibrinogen** – r = 0.085 < 0.001 3.32 ± 0.52 3.38 ± 0.52 t = − 3.269 0.001
hs-CRP ln*** – r = 0.084 < 0.001 0.52 ± 1.06 0.71 ± 1.01 t = − 4.939 < 0.001
*N = 4848
**N = 3744
***N = 3826
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complaints, and again, this finding is congruent with the
literature [30, 38], with the most economically deprived in-
dividuals being at greatest risk of poor mental and physical
health. Our findings on the association between depressive
symptoms and sleep complaints and cohabitation are also in
line with past research showing marriage has largely positive
effects on depressive symptoms [39] and sleep [40].
Interestingly, we found evidence that greater depressive
symptoms and sleep complaints were associated with low
alcohol consumption; this is largely inconsistent with
previous literature [41, 42], although health benefits of mod-
erate alcohol consumption, defined as 1 to 3 alcoholic drinks
per day, have been reported for both outcomes [32, 43]. In
our analyses, frequency of alcohol consumption was mea-
sured on a scale from more than five times a week to rarely
or never; as such, our highest frequency category may over-
lap with the definition of moderate drinking provided by
Ferrerira and Weems [43]. More research is needed to cor-
roborate whether moderate drinking on a regular basis con-
fers depression and sleep benefits.
Table 3 Baseline
sociodemographic and
behavioural variables predicting
depressive symptoms and sleep
complaints at follow-up (N =
4848)
Depressive symptoms Sleep complaints
β 95% CI p OR 95% CI p
Baseline depressive symptoms 0.397 0.365–0.422 < 0.001 6.795 5.860–7.879 < 0.001
Baseline sleep complaintsa 0.067 0.135–0.311 < 0.001 1.138 1.083–1.195 < 0.001
Baseline depressive symptoms ×
sleep complaints interaction
0.030 0.012–0.170 0.024 0.836 0.724–0.965 0.015
Age (years) 0.044 0.003–0.013 0.002 0.998 0.989–1.007 0.671
Sexb 0.021 − 0.014–0.145 0.108 1.380 1.186–1.605 < 0.001
Ethnicityc 0.024 − 0.004–0.604 0.053 0.952 0.539–1.681 0.864
Relationship statusd 0.015 − 0.042–0.143 0.282 0.740 0.621–0.883 0.001
Wealth − 0.028 − 0.062–0.000 0.047 –
1 (lowest) – Reference
2 0.903 0.707–1.154 0.415
3 0.838 0.652–1.075 0.164
4 0.768 0.596–0.991 0.042
5 (highest) 0.674 0.518–0.878 0.003
Smokere − 0.044 − 0.326–0.084 0.001 0.761 0.609–0.950 0.016
Alcohol consumption 0.022 − 0.007–0.073 0.108 –
> 5 times/week – Reference
1–4 times/week 1.005 0.831–1.215 0.959
Occasionally 1.005 0.801–1.262 0.963
Rarely/never 1.137 0.899–1.437 0.283
Physical activityf − 0.039 − 0.212–0.044 0.003 0.830 0.705–0.978 0.026
BMI (kg/m2) 0.053 0.008–0.023 < 0.001 1.016 1.002–1.031 0.026
Hypertensiong − 0.006 − 0.098–0.062 0.659 0.976 0.839–1.136 0.753
CHDg 0.014 − 0.061–0.208 0.287 1.168 0.914–1.492 0.214
Strokeg 0.019 − 0.051–0.368 0.137 1.146 0.785–1.672 0.480
Diabetes/high blood glucoseg 0.019 − 0.036-0.234 0.152 1.034 0.807–1.326 0.789
Cancerg 0.006 − 0.136-0.221 0.640 1.125 0.810–1.562 0.483
Pulmonary diseaseg 0.032 0.054–0.440 0.012 1.312 0.932–1.848 0.120
Arthritisg 0.050 0.076–0.240 < 0.001 1.363 1.174–1.583 < 0.001
N.B. italic script denotes signifcant results at p < 0.05
a Low sleep complaints
bMale
cWhite
dMarried/cohabiting
e Smoker
fModerate/vigorous physical activity < 1 a week
gNot reported
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Both depressive symptoms and high sleep complaints were
associated with a range of negative health factors, including
cardiovascular diseases (i.e. hypertension, stroke, CHD), ar-
thritis, pulmonary disease, higher BMI, and higher levels of
fibrinogen, and hs-CRP. This corroborates research suggest-
ing both depression [27, 44] and poor sleep [45] are associated
with higher levels of inflammation. Obesity is known to be
associatedwith higher levels of inflammation [46] as are phys-
ical illnesses, potentially contributing to these findings.
Our prospective findings only partly supported our cross-
sectional analyses. Specifically, the only baseline factors that
predicted both sleep complaints and depressive symptoms at
follow-up were poor sleep, greater depressive symptoms, rel-
ative poverty, higher BMI, smoking, physical inactivity, and
arthritis. In individual models, elevated depressive symptoms
were predicted by baseline depressive symptoms and sleep
complaints, older age, higher BMI, pulmonary disease and
arthritis, while not smoking, engaging in regular physical ac-
tivity and higher wealth were protective factors. As previously
discussed, smoking, physical inactivity and low socioeconom-
ic status are known to be associated with depression [36, 38,
47]. Our data suggest these factors may precede depression in
the temporal pathway. In terms of increased future risk of
sleep complaints, we found that female sex, higher BMI and
arthritis were all significant predictors, while not smoking,
engaging in regular physical activity, cohabitation and higher
wealth were protective factors. It has been long recognised
that women are more likely to report poor sleep [30]. Meta-
analytic reviews suggest that poor and short sleep increase the
risk of obesity and chronic physical conditions [18] but the
link between poor sleep and physical health is bi-directional
[48], and it is plausible that excess weight and arthritis, which
is often a source of considerable pain, may seriously disturb
the ability to sleep [49, 50]. The association between pain and
arthritis has also been suggested as a reason why rheumatoid
arthritis is often associated with depression [51]; this may
partly explain the association we found here between arthritis
and depression.
The reason why the other sociodemographic, behavioural,
clinical, and biological factors were not significant in prospec-
tivemodels is interesting and informs our understanding of the
causal associations between these factors. Particularly notable
is the lack of prospective association found between the clin-
ical and biological factors and future depressive symptoms
and sleep complaints. Previous research has supported the
association between physical illness and future depression
[52] and inflammatory markers have been shown to be asso-
ciated with disrupted sleep, particularly in clinical populations
[53]. We can only speculate why in our data physical illness
(except pulmonary disease and arthritis), hs-CRP and fibrino-
gen did not predict future sleep complaints and depressive
symptoms. It is plausible that inflammatory factors may im-
pact sleep and depression when more severe or persistent
levels of inflammation, sleep or depressive symptoms are
present [54], as reported in those with clinically diagnosed
depression [53, 55]. Moreover, we were unable to take into
account disease stage, disease severity, and treatment of dis-
eases that could possibly mask symptoms, which may all im-
pact the prospective association with depressive symptoms
and sleep complaints. Finally, since sleep data were only in-
troduced in ELSA at wave 4, our follow-up analysis was re-
stricted to 4 years which may preclude a significant associa-
tion from being detected.
We found that future high sleep complaints were predicted
by baseline depressive symptoms only among those with low
sleep complaints at baseline. Moreover, future depressive
symptoms were only predicted by sleep complaints in those
with low depressive symptoms at baseline. These results re-
quire careful interpretation given there were few participants
with high depression symptoms and low sleep complaints in
our sample. However, they do add to a growing literature on
the causal sequence between sleep and depression. Our find-
ings could be considered to partly support the work of
Skapinakis and colleagues [19] who suggest that their results
of a strong cross-sectional association between poor sleep and
depression, but lack of prospective association, perhaps points
to sleep complaints being a prodromal or residual symptom of
depression. Future work is needed to understand these effects
in greater detail. However, our findings suggest the impor-
tance of taking into account the interaction between sleep
and depression symptoms in understanding these longitudinal
effects and that sleep complaints and depressive symptoms
both require targeted interventions and treatment. Indeed,
combining standard antidepressant treatment with cognitive
behavioural therapy for insomnia in patients with major de-
pression disorder has been found to be associated with faster
and more durable remission from depression than treatment
with antidepressants alone [56]. There is also evidence that
improving sleep quality in older adults with insomnia is asso-
ciated with a reduction in the biological markers of disease
including inflammatory markers [57]. This is important given
the close link between inflammation and depression [44].
Our study has a number of strengths. We used a large and
well-described cohort of community-dwelling older men and
women from England [20]. The results described here include
prospective analyses with participants being followed for
4 years to shed light on the risk factors for future depressive
symptoms and sleep complaints. Because a large number of
data are collected as part of ELSA, which includes informa-
tion on psychological and socioeconomic factors, leisure ac-
tivities, health behaviours and physical health indicators, this
reduces the possibility that participants were aware of our
interests in depressive symptoms and sleep described here.
However, our conclusions are tempered by a number of lim-
itations that need to be borne in mind. First of all, sleep was
measured with self-report that is prone to affect and memory
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biases [58] as well as inaccuracies when compared with ob-
jective sleep indicators. The Jenkins sleep scale showed low
internal consistency in our sample, though this in line with the
original validation data for this questionnaire [20] suggesting
there is a need for future scale development in this field.We do
not have information on sleep disorders such as sleep apnoea
or sleep medication since these are not assessed in ELSA.
Similarly, depressive symptoms were assessed using the
CES-D and therefore our observations are limited to eleva-
tions in depressive symptoms and not clinical depression.
Finally, although self-report measures of physical illnesses
have been shown to be reliable in previous cohort studies
[59], to circumvent possible measurement error, we grouped
together osteoarthritis and rheumatoid arthritis cases; therefore
we are unable to tease apart the effects of these two distinct
illnesses.
In conclusion, our findings showed that older men and
women reporting elevated depressive symptoms and/or sleep
complaints shared a range of sociodemographic, behavioural,
biological and clinical correlates. Prospective analyses re-
vealed that the only common risk factors for elevated depres-
sive symptoms and sleep complaints 4 years later were elevat-
ed baseline depressive symptoms and sleep complaints,
smoking, physical inactivity, BMI, arthritis and wealth.
Collectively, our findings highlight the common comorbidity
between depressive symptoms and sleep complaints which
underscores the need for further research to understand their
combined detrimental effects on long-term health and
wellbeing.
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